According to a new report published by Allied Market Research titled, “Anti-Rheumatics Market by Drug Class (Disease Modifying Anti-Rheumatic Drugs (DMARD’s), Nonsteroidal Anti-Inflammatory Drugs (NSAID’s), Corticosteroids, Uric Acid Drugs, and Others), Type (Prescription-Based Drugs and Over-the-Counter Drugs): Global Opportunity Analysis and Industry Forecast, 2019–2026″. The global anti-rheumatics market accounted for $57,229 million in 2018 and is expected to reach $71,934 million by 2026, registering a CAGR of 2.9% from 2019 to 2026. 

Increase in incidence of rheumatoid arthritis, surge in geriatric population, and rise in incidence of obesity across the world drive the growth of the global anti-rheumatics market. However, side effects related to the medication and higher cost of biologics & biosimilars hinder the growth of the market. On the other hand, R&D activities in the field of biosimilars and novel biologics present numerous opportunities in the market.

For Right Perspective and Competitive Insights, Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/6289

Comprehensive competitive analysis and profiles of major market players, such as:

  • Pfizer, Inc.
  • Johnson & Johnsons
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Celegene Corporations
  • MedImmune, LLC
  • Takeda Pharmaceutical Company Ltd.
  • Biogen Inc.
  • Celltrion Inc.
  • Amgen Inc.

Key Findings of the Study: 

  • The disease modifying anti-rheumatic drugs segment occupied approximately two-fifth share of the global anti-rheumatics market in 2018.
  • The nonsteroidal anti-inflammatory drugs segment is anticipated to grow at the highest CAGR throughout the forecast period.
  • The prescription-based drugs segment accounted for three-fourth share of the market in 2018.
  • Asia-Pacific is anticipated to grow at the fastest rate during the analysis period, followed by LAMEA.

North America to lead in terms of revenue during the forecast period

Based on region, North America held the highest share in 2018, accounting for nearly one-third of the global anti-rheumatics market, and will lead during the forecast period. This is due to easy availability of anti-rheumatics and increase in geriatric population that are susceptible to nephrological disorders. However, Asia-Pacific is estimated to witness the largest growth rate, with a CAGR of 3.7% from 2019 to 2026. This is attributed to increase in healthcare expenditure and surge in awareness of anti-rheumatics.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6289

FREQUENTLY ASKED QUESTIONS?

Q1. What was the size of the global Anti-Rheumatics Market in 2021?
Q2. How much will the global Anti-Rheumatics Market be worth in the future?
Q3. What would be forecast period in the market report?
Q4. What are the segments of Anti-Rheumatics Market?
Q5. The global Anti-Rheumatics Market is segmented on the basis of product type, connectivity, distribution channel, and region.

Similar Report :-

Body Composition Analyzers Market

Middle East Disposable Gloves Market

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.